Status:
COMPLETED
Insulin Initiation and Adherence Behaviours: a Cross Sectional Survey of Indian HCPs & Patients With Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
This is a cross-sectional study planned among patients with Type 2 Diabetes (T2D) and Health Care Providers (HCPs) who treat T2D patients. Study participants will be recruited through existing databas...
Eligibility Criteria
Inclusion
- For patients
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, age above or equal to 18 years at the time of signing informed consent.
- Diagnosed with T2D
- Currently seeing an HCP for T2D
- Initiated on insulin within the past 12 months
- Prescribed insulin on a permanent basis
- Currently taking insulin via a vial and syringe or insulin pen
- For HCP
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male or female, age above or equal to 18 years at the time of signing informed consent.
- Primary care physician (PCP) with degree in internal medicine or general medicine, diabetologist with degree in internal medicine or general medicine plus diploma in diabetology, or endocrinologist
- Has been in practice a minimum of 2 years
- Diabetologist/endocrinologist: treats at least 50 T2D patients per month
- PCP: treats at least 40 T2D patients per month
- Currently initiates T2D patients on insulin
- Treats 20 percent or more of T2D patients with insulin
Exclusion
- Previous participation in this study. Participation is defined as having given informed consent in this study
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Key Trial Info
Start Date :
July 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2024
Estimated Enrollment :
752 Patients enrolled
Trial Details
Trial ID
NCT06517784
Start Date
July 5 2024
End Date
August 16 2024
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk India
Bangalore, India